John C. Jacobs

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Plymouth Meeting, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Mark J. Casey, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John C. Jacobs

Form 4 holding President and CEO, Director

NOVAVAX INC

Security class
Non-Statutory Stock Option NQ
Shares / value
551,500
Estimated value
$5,013,135
Report date
02 Mar 2026
Price
$9.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

NOVAVAX INC

Security class
Common Stock
Shares / value
225,680
Estimated value
$2,024,349
Report date
03 Mar 2026
Price
$8.97
Ownership
Direct
Form 4 holding President and CEO, Director

NOVAVAX INC

Security class
Restricted Stock Units
Shares / value
300,333
Estimated value
$1,388,328
Report date
03 Mar 2026
Price
$8.33
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding PRESIDENT, CEO, Director

Harmony Biosciences Holdings, Inc.

Security class
Stock Option
Shares / value
114,751
Estimated value
Report date
15 Aug 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John C. Jacobs

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .